Parliament rally to present eight petitions for more PHARMAC funding for medicines

7 May 2019 - A woman who suffers a rare disorder is just out of hospital but she's determined to ...

Read more →

PHARMAC Chairman backs early access scheme for new drugs

7 May 2019 - PHARMAC board chairman Steve Maharey is backing an early access scheme that would give patients access ...

Read more →

Proposal to widen access to etanercept and award sole supply

3 May 2019 - PHARMAC is proposing to make changes to the funding of etanercept, a biologic medicine used to ...

Read more →

Decision to amend the distribution and access criteria for dasatinib (Sprycel)

3 May 2019 - PHARMAC has a made a decision to change the distribution arrangements and access criteria for the ...

Read more →

PHARMAC funding: how it works - and the changes its critics want

6 May 2019 - PHARMAC will again be thrust into the spotlight tomorrow when New Zealanders rally at Parliament calling ...

Read more →

Why PHARMAC won't fund lifesaving EpiPens

1 May 2019 - Epipens can be the difference between life and death for people who have food allergies but, ...

Read more →

New Zealand Pharmaceutical Schedule - 1 May 2019 update

1 May 2019 - The May 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Health groups to present multiple petitions

30 April 2019 - Health groups marching to Parliament to present multiple petitions ...

Read more →

Beefed-up PHARMAC funding would be welcome Budget boost

30 April 2019 - In just four weeks' time, the Finance Minister will deliver the Government's Wellbeing Budget. ...

Read more →

Proposal to decline inactive applications

29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...

Read more →

PHARMAC proposes to give more clarity about funding decisions

29 April 2019 - An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and ...

Read more →

PHARMAC failure to fund effective contraceptive 'embarrassing'

26 April 2019 - A decision to not fully fund one of the most effective contraceptive devices in the world ...

Read more →

NZORD supports rare medicine petitions to government

23 April 2019 - The National Organisation for Rare Disorders supports petitions for more effective, equitable outcomes for people with ...

Read more →

No outcomes on breast cancer drugs Kadcyla and Ibrance yet, says PHARMAC

24 April 2019 - PHARMAC has reiterated that it has not yet made a decision on whether to fund two ...

Read more →

PHARMAC rejects own experts' view on breast cancer drug

23 April 2019 - PHARMAC has refused funding for Kadcyla, an important drug that has recently had a high media ...

Read more →